The ultimate in transfer from brain training to real-world outcomes: Reducing the risk of at-fault accidents by almost 50%

___ Can you train your brain to dri­ve longer into your gold­en years? (CTV News): “For the elder­ly, the loss of a driver’s licence could mean the end of inde­pen­dence and the begin­ning of a decline in health, with far-reach­ing con­se­quences in their dai­ly lives…New assis­tive dri­ving tech­nolo­gies seem like an obvi­ous solu­tion in the years…

Read More

5 Facts You Need To Know To Understand, Navigate And Enjoy The Digital Brain Health Revolution

— Hun­dreds of com­pa­nies around the globe, now includ­ing Elon Musk’s Neu­ralink and even Face­book,  are research­ing and devel­op­ing new ways to help brain own­ers be smarter, sharp­er, and health­i­er. What explains this flur­ry of activ­i­ty? Where may it be head­ed? To help you under­stand what’s going on, let me high­light five key facts that emerged…

Read More

Testing and training cognitive ability: Key Neurotech Patent #16

training cognitive ability

Today we are fea­tur­ing a key 2003 patent assigned to Cog­nifit ltd — fas­ci­nat­ing to reflect how the brain train­ing field has evolved in 14 years! (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date) U.S. Patent No. 6,632,174: Method and Appa­ra­tus for test­ing and train­ing cog­ni­tive ability…

Read More

Study debunks 4 common myths about brain training and lifelong cognitive enhancement

— If the media is your main source of infor­ma­tion about brain train­ing and cog­ni­tive enhance­ment, you will prob­a­bly believe the fol­low­ing: 1) All brain train­ing is the same… 2) …and it sim­ply does­n’t work. 3) Com­mer­cial brain train­ing pro­grams, espe­cial­ly, don’t work. 4) How could they work? Genet­ics is des­tiny, aging is a pre­de­ter­mined process…so by age 60…

Read More

Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution

Mer­ck KGaA In Deal With HAP­PYneu­ron To Offer E‑Health Solu­tion For MS Patients (Nas­daq): “Ger­man drug mak­er Mer­ck KGaA (MKGAY.PK) announced Mon­day that it has entered into an agree­ment with HAP­PYneu­ron, a sub­sidiary of SBT Group of France, in which Mer­ck will receive an exclu­sive license to the com­pa­ny’s cog­ni­tive reme­di­a­tion train­ing pro­gram for people…

Read More